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Background: Although HIV continues to have a high prevalence among adults in sub-Saharan 33 
Africa (SSA), the burden of noncommunicable diseases (NCD) such as diabetes and 34 
hypertension is increasing rapidly. There is an urgent need to expand the capacity of healthcare 35 
systems in SSA to provide NCD services and scale up existing chronic care management 36 
pathways. The aim of this study was to identify key components, outcomes, and best practice 37 
in integrated service provision for the prevention, identification and treatment of HIV, 38 
hypertension and diabetes. 39 
Methods: An international, multi stakeholder e-Delphi consensus study was conducted over 40 
two successive rounds. In Round 1, 24 participants were asked to score 27 statements, under 41 
the headings ‘Service Provision’ and ‘Benefits of Integration’, by importance. In Round 2, the 42 
16 participants who completed Round 1 were shown the distribution of scores from other 43 
participants along with the score that they attributed to an outcome and were asked to reflect 44 
on the score they gave, based on the scores of the other participants and then to rescore if they 45 
wished to. Nine participants completed Round 2. 46 
Results: Based on the Round 1 ranking, 19 of the 27 outcomes met the 70% threshold for 47 
consensus. Four additional outcomes suggested by participants in Round 1 were added to 48 
Round 2, and upon review by participants, 22 of the 31 outcomes met the consensus threshold. 49 
The five items participants scored from 7-9 in both rounds as essential for effective integrated 50 
healthcare delivery of health services for chronic conditions were improved data collection and 51 
surveillance of NCDs among people living with HIV to inform integrated NCD/HIV 52 
programme management, strengthened drug procurement systems, availability of equipment 53 
and access to relevant blood tests, health education for all chronic conditions, and enhanced 54 
continuity of care for patients with multimorbidity. 55 
Conclusions: This study highlights the outcomes which may form key components of future 56 
complex interventions to define a model of integrated healthcare delivery for diabetes, 57 
hypertension and HIV in sub-Saharan Africa.  58 
Keywords: HIV, healthcare utilization, noncommunicable diseases, integration, service 59 
delivery, sub-Saharan Africa 60 
INTRODUCTION 61 
While HIV continues to have a high prevalence in sub-Saharan Africa (SSA) among adults, 62 
the burden of noncommunicable diseases (NCD) is increasing rapidly, in particular diabetes 63 
and hypertension (1). Each year over three-quarters (28 million) of global NCD deaths and 64 
most premature deaths from NCDs (82%) occur in low-to-middle-income-countries (LMICs). 65 
Cardiovascular diseases account for most NCD deaths, 17.9 million people annually, followed 66 
by cancers (9.3 million), respiratory diseases (4.1 million), and diabetes (1.5 million) (2). The 67 
International Diabetes Federation reported that the prevalence of diabetes in SSA is anticipated 68 
to double between 2010 and 2030 (3). It is estimated that of approximately 650 million people 69 
in SSA, 10-20 million may have hypertension (4). However, these estimations are based on 70 
scarce heterogenous studies and many countries in SSA still lack detailed up-to-date basic data 71 
on the prevalence of hypertension (5). NCDs are important contributors to the burden of disease 72 
in countries at all stages of economic development. However, the Global Status Report on 73 
NCDs emphasizes that the negative impacts of NCDs are particularly detrimental to 74 
populations with high poverty such as SSA (6), as poverty exacerbates many health conditions 75 
(7).  76 
In recent years, there have been rapid improvements in HIV care programmes in SSA. 77 
Substantial global investment in health services has strengthened physical infrastructure, 78 
laboratory capacity, health information systems, healthcare worker capacity development and 79 
promoting delivery of antenatal care, family planning and sexually transmitted infection (STI) 80 
management (8). This has led to the expansion of and improvements in life-saving 81 
antiretroviral therapy (ART) which has greatly decreased HIV related morbidity and mortality 82 
(9). Currently, about 65% of all people living with HIV (PLHIV) in Africa regularly access 83 
care with antiretroviral therapy (10). However, this has resulted in an ageing population of 84 
PLHIV, with the population becoming more susceptible to NCDs, such as diabetes and 85 
hypertension (11).  In contrast, health service provision for NCDs in SSA remains poor and 86 
evidence on adherence to treatment and retention in care is limited with only 5-20% of people 87 
with diabetes or hypertension thought to be in regular care (12). There is an urgent need to 88 
expand the capacity of healthcare systems in SSA to provide services for managing HIV and 89 
one or more NCDs concurrently. 90 
Within healthcare systems in SSA, as concern about the management of NCDs among PLHIV 91 
grows, the infrastructure and lessons learnt from the HIV chronic disease management model 92 
are important resources for those hoping to expand NCD prevention, care, and treatment (13). 93 
These include health services which are stand-alone and vertically delivered and have been 94 
combined with decentralisation and task shifting, allowing primary health centres to treat large 95 
numbers of patients with almost 70% of people living with HIV-infection in regular care (14). 96 
Given the similarities between different chronic diseases (their effects on health and individual 97 
functioning share common pathways and outcomes), the healthcare systems, assessment tools 98 
to diagnose and manage patients, health professional capacity and implementation strategies 99 
developed to provide continuity of care for HIV in SSA means they can potentially be rapidly, 100 
efficiently, and effectively utilized to support services for NCDs, particularly  hypertension 101 
and diabetes (13).  102 
Potential benefits of HIV-NCD integration for the health system and patients include a 103 
reduction in duplication and fragmentation of services, which would increase efficiency of 104 
resource use and help patients remain in care by reducing costs and inconvenience for patients 105 
with multiple morbidities (15). Furthermore, screening for NCDs within HIV care programmes 106 
can improve the identification of undiagnosed NCDs among patients living with HIV and also 107 
contribute to improved health outcomes (16). Leveraging and adapting the existing HIV model 108 
to integrate with newly developing NCD services is key to achieving integrated care systems 109 
that are more convenient for patients. However, although a number of models of integrated 110 
HIV/NCD care in SSA have been established in recent years, the lack of evidence-based care 111 
models for scaling up integrated care makes it difficult for countries to develop effective and 112 
contextually appropriate policy and practice based strategies (17).  113 
Given the importance of integrated care models to address the issues outlined above, the aim 114 
of this study was to determine consensus among experts on key components/outcomes and best 115 
practices in integrated service provision for the prevention, identification and treatment of HIV, 116 
hypertension and diabetes. 117 
 118 
METHOD 119 
The study design utilised an international, multi-stakeholder e-Delphi consensus study over 120 
two successive rounds. A web-based system designed to facilitate the building and 121 
management of Delphi surveys (DelphiManager, http://www.comet-122 
initiative.org/delphimanager/), was used for data collection. The Delphi consensus technique 123 
is a survey method designed to obtain the opinions of a group of experts on a topic, with each 124 
round providing input to the next (18). This technique differs from other group decision making 125 
processes in four ways:  utilising anonymity, iteration and controlled feedback, statistical group 126 
response and expert input (19). The Delphi approach is an iterative consensus technique that 127 
presents a series of sequential questionnaires asking individuals to rank outcomes in terms of 128 
priority for inclusion in a key components/outcome set that should be used in interventions to 129 
optimise the prevention, identification and treatment of HIV, diabetes and hypertension in 130 
integrated services in the SSA context.  131 
This Delphi consensus study used two rounds with participants being informed of the results 132 
of the prior round and allowed to revise their opinion based on those results. The goal was to 133 
achieve a pre-defined threshold of consensus. Key to the Delphi approach is the anonymity of 134 
participants. By ensuring that participants remain anonymous throughout the process, they are 135 
free to revise their opinion without fear of reputational harm or to refuse to revise their opinion 136 
without pressure from the group to do so (20).  137 
Data were collected from the selected group of global expertson integrating diabetes, 138 
hypertension and HIV Care in SSA by using formal consensus methods, defined as “group 139 
facilitation techniques designed to explore the level of consensus among a group of experts by 140 
synthesising and clarifying expert opinions.” (21).  141 
Selection of experts 142 
Consistent with the purposive sampling approach used by many Delphi studies (20), our 143 
sampling strategy focused on identifying potential experts on the topic of interest and inviting 144 
them to participate in the study. We identified potential experts  through the ‘INTE-AFRICA’ 145 
consortium (n=39) (22) and by contacting the corresponding authors of manuscripts from a 146 
scoping review we conducted on integrating care for diabetes, hypertension and HIV in SSA 147 
(n=38) (23). Expressions of interest to participate in the study were sought from the 77 148 
identified experts.  149 
Twenty-four participants returned an expression of interest form and were sent an email 150 
invitation that included information about the purpose and process of the study and a link to 151 
the online version of the questionnaire in DelphiManager. The size of Delphi panels can range 152 
widely and the 24 participants that agreed to participate in this study is within the 10-50 153 
typically recommended (24). We asked the experts to commit their participation for two 154 
planned Delphi rounds and informed consent was obtained from all participants. Participants 155 
were recruited between December 2019 and January 2020. Consistent with the COMET 156 
methodology, we included researchers, policymakers, and academics in our sample of experts 157 
to ensure a broad representation of opinions (Table 1). The establishment of this panel was 158 
overseen by the INTE-AFRICA Work Package 3 steering group which was responsible for 159 
providing advice, ensuring delivery of Work Package 3 project outputs. The Delphi panel 160 
participants received no financial incentive to participate in the study.  161 
<< Insert Table 1 here >> 162 
Round 1 163 
Participants were asked to score the importance of 27 statements developed by the steering 164 
group (22) (see Tables 2 and 3) on a 9-point Likert scale. The statements were grouped under 165 
two headings, (Service Provision and Benefits of Integration) which were identified as being 166 
important to enhancing integration of diabetes and hypertension management with HIV 167 
management in SSA. For outcomes under the heading ‘Service Provision’ participants were 168 
asked to rate outcomes on a scale of 1-9 where 1 = lowest priority and 9 = highest priority. For 169 
outcomes under the heading ‘Benefits of Integration’ participants were asked to rate outcomes 170 
on a scale of 1-9 where 1 = strongly disagree and 9 = strongly agree. The Likert scale 171 
corresponds to the conventional format used for comparative assessment and prioritisation of 172 
different health options (25). Participants could suggest additional outcomes during Round 1 173 
by adding their suggested outcome(s) in a free text box. Due to time constraints for completing 174 
the study, participants were given a period of one week to complete round 1 of the survey and 175 
a reminder email was sent to those participants who had not yet completed the survey two days 176 
prior to the Round 1 deadline. Eighteen participants participated in Round 1 (with two partial 177 
completions, therefore 16 participants completed). Suggested outcomes from Round 1 were 178 
independently reviewed and coded by the first and second author to determine their novelty 179 
(i.e., that they were not covered by existing outcomes in the questionnaire). The first two 180 
authors could not reach agreement on whether to include two of the suggested outcomes, so 181 
clarification was sought from the last author (WC)and consensus was reached to include four of the 182 
10 suggested outcomes   in Round 2.. 183 
Round 2 184 
Round 2 included the 27 original outcomes, and four additional outcomes suggested by 185 
respondents in Round 1. The 16 participants, who had completed Round 1, were shown the 186 
distribution of Round 1 scores from other participants along with the score that they attributed 187 
to an outcome. Participants were asked to reflect on the score they had given to each statement, 188 
based on the scores of the other participants. Using the same 9-point Likert scale, they were 189 
invited to rescore if they wanted to. Participants were given one week to complete the second 190 
round of the survey. Through this process, consensus was reached on key 191 
components/outcomes, best practice, and likely benefits in integrated service provision for the 192 
prevention, identification and treatment of HIV, hypertension, and diabetes in SSA. 193 
Analysis 194 
Data analysis was conducted using DelphiManager software. The DelphiManager software 195 
provided the user scores data for each statement. Consensus for each of the statements was 196 
defined a priori as 70% or more of the respondents scoring an outcome from seven to nine and 197 
fewer than 15% scoring it one to three. Meeting the consensus meant an outcome falling in 198 
both categories of threshold  ≥70% and <15%,  The cut-off points were selected based on the 199 
most widely used cut of points in Delphi studies (18, 24, 26).  This would illustrate an outcome 200 
agreed as critically important by the majority and as of little or no importance by a small 201 
minority. Although there is no formal guidance for the reporting of e-Delphi studies, we 202 
followed recommendations including that patients and clinicians be involved; researchers and 203 
facilitators avoid imposing their views on participants; and attrition of participants be 204 
minimised as outlined by Sinha et al. (27). 205 
Ethical considerations  206 
Ethical approval for the study was granted by the Human Research Ethics Committee at 207 
University College Dublin (LS-19-91-Cullen) and all methods were performed in accordance 208 
with the relevant guidelines and regulations. Participants were made aware that taking part in 209 
the study was optional and they could withdraw their participation at any time without reason. 210 
All anonymous information was securely stored on a password protected hard drive. 211 
 212 
RESULTS 213 
Round 1  214 
Of the 24 participants who were invited to take part in the study, 18 participated in Round 1 (6 215 
of the invited participants did not commence Round 175% response rate). Participants’ ranking 216 
of outcome measures for Round 1 is provided in Tables 2 and 3. 217 
<< Insert Table 2 and 3 here >> 218 
Based on Round 1 ranking, 19 of the 27 outcomes for ‘Service Provision’ & ‘Benefits of 219 
Integration’ combined met the consensus threshold of ≥70% respondents scoring an outcome 220 
from seven to nine and <15% scoring it one to three. (combined consensus rate = 70.4%). 221 
With regards to the ‘Service Provision’ items, 11 outcomes met the consensus thresholds 222 
(consensus rate = 73.4%), whilst 4 outcomes (consensus rate = 26.7%) did not. Of the 4 223 
outcomes that did not meet thresholds, one item (‘It is important that referral networks from 224 
primary to secondary care are not adversely affected by integrated care delivery in primary 225 
care’) did meet the < 15% threshold, but not the ≥ 70% requirement. Meanwhile, for the 12 226 
Round 1 ‘Benefits of Integration’ items, 8 items met the thresholds (consensus rate= 6.7%), 227 
and four did not (consensus rate =  33.4%) Of the items that did not meet the thresholds, two 228 
(‘Patients are likely to receive better quality of health education within the integrated clinic as 229 
within current vertical care clinics’ and ‘Patients are likely to spend less time waiting in an 230 
integrated clinic’) met the < 15% threshold, but not the ≥70% criteria. Those statements for 231 
which all respondents scored 7-9 and statements for which most respondents scored 1-3 are 232 
illustrated in Tables 2 and 3.  233 
 234 
Round 2 235 
Nine of Round 1’s 18 participants took part in and completed Round 2. Round 1’s participants 236 
suggested that four outcomes be added in Round 2, thus resulting in a new tally of 31 items for 237 
the combined measures. Two outcomes were added to the ‘Service Provision’ measure 238 
(‘Integrated clinics may need to be re-launched to avoid being labelled as HIV clinics’ and ‘All 239 
health workers should undergo training in the provision of integrated chronic care’) and two 240 
were added to the ‘Benefits of Integration’ measure (‘Acceptability of integration of diabetes 241 
and hypertension with HIV may not be acceptable to all patients’ and ‘The success of integrated 242 
care depends on how well the stakeholders work together’). Twenty-two of the 31 outcomes 243 
(consensus rate = 71.0%) met the ≥70% and < 15% criteria. For the 15 items that were also 244 
on Round 1’s ‘Service Provision’ measure, 13 met the threshold criteria. Two items that did 245 
not meet the criteria in Round 1 did so in Round 2. These items were ‘Drug procurement 246 
systems for NCDs and HIV should be integrated’ and ‘It is important that referral networks 247 
from primary to secondary care are not adversely affected by integrated care delivery in 248 
primary care’. Meanwhile, of the two items that were added to Round 2, neither met the 249 
criteria. The second of these items ‘All health workers should undergo training in the provision 250 
of integrated chronic care’ did meet the ≥ 70% mark, but not the < 15% threshold. As for 251 
Round 2’s ‘Benefits of Integration’ measure, 7 items (consensus rate = 58.4%) did meet the 252 
threshold criteria and 5 (consensus rate = 41.7%) did not.  One item that met the criteria in 253 
Round 1 did not do so in Round 2. This item was ‘Integrated care for diabetes, hypertension 254 
and HIV can occur within the HIV care programme’. Of the two items that were added to 255 
Round 2’s ‘Benefits of Integration’ measure, one met the threshold criteria. This was the 256 
‘…success of integrated care depends on how well the stakeholders work together’ measure.  257 
Those statements for which all respondents scored 7-9 and statements for which most 258 
respondents scored 1-3 are illustrated in Tables 2 and 3. Those statements for which all 259 
respondents scored 7-9 on both rounds are illustrated in Tables 2 and 3.  260 
 261 
DISCUSSION 262 
This study sought to identify key components/outcomes and best practices in integrated service 263 
provision for the prevention, identification and treatment of HIV, hypertension, and diabetes. 264 
The results of our e-Delphi study suggest that key experts largely agree on what key 265 
components/outcomes and best practices should be involved when addressing the high and 266 
increasing dual burden of NCDs and HIV in sub-Saharan Africa.   267 
The highest priority for service provisions was given to the strengthening of drug procurement 268 
systems for NCDs within an integrated care programme and the availability of equipment and 269 
access to relevant blood tests for routine monitoring for all conditions. Health education and 270 
community-based education programmes and services were also prioritised to address the 271 
stigma within NCD/HIV care. There should be onsite training of healthcare workers on HIV 272 
and NCDs. Participants also believed improved data collection and surveillance of NCDs 273 
among PLHIV should be used to inform integrated NCD/HIV programme management.  274 
The results showed that participants strongly agreed that an integrated clinic would provide 275 
better continuity of care and clinical outcomes for patients with multi-morbidities. They believe 276 
patients with chronic diseases are more likely to be retained in an integrated care clinic and this 277 
care can be delivered in the community. Additionally, participants strongly disagreed that 278 
integrating these services may weaken the current HIV programme. One item that met the 279 
criteria in Round 1 did not do so in Round 2. This is a common occurrence with the Delphi 280 
consensus technique as participants are shown the distribution of Round 1 scores from other 281 
participants and asked to reflect on their own Round 1 score and are invited to rescore if they 282 
wanted to. 283 
How this relates to other literature  284 
Although this topic has been studied before (28-30), the best practices in integrated care 285 
provision for the prevention, identification and treatment of hypertension, diabetes and HIV in 286 
SSA has yet to be identified. This study provides a unique perspective by a group of experts 287 
on the topic in order to inform best practice in integrated care provision. The results of this 288 
study reaffirm the view that an integrated clinic will provide better continuity of care for 289 
patients with diabetes, hypertension and HIV. 290 
Barriers such as a lack of diagnostic equipment and medication (17, 31), lack of trained staff 291 
or training (31, 32) lack of guidelines and operating protocols (33), and perceived threat of 292 
integration to existing HIV success (34) have all been cited as issues when implementing 293 
integrated HIV/NCD care in SSA.  These barriers were also highlighted by participants in this 294 
study as the need to strengthen (35) drug procurement systems for NCDs, improve the 295 
availability of equipment, and access to relevant blood tests for routine monitoring for all 296 
conditions were all strongly agreed upon. Health education and community-based education 297 
programmes and services were also prioritized. 298 
The results of this study add to the existing literature by highlighting the most important service 299 
provisions and perceived benefits of integration, and particularly useful for the African context 300 
where integrated care is developing. This can be used as a guide to determining key outcomes 301 
and interventions in future trials.  302 
Limitations and Strengths 303 
This study employed the ‘Delphi’ consensus technique in an attempt to identify key 304 
components/outcomes and best practice in integrated service provision for the prevention, 305 
identification and treatment of HIV, hypertension, and diabetes. The validity of study findings 306 
depends on the composition of our e-Delphi panel. Recommended best practices in an e-Delphi 307 
study is to involve a diverse set of panellists (24). The presence of diverse perspectives is likely 308 
to result in wider acceptance of the prioritized outcomes deemed important to include in future 309 
trials. To minimise recruitment bias, we invited a range of global and African stakeholder 310 
groups (researchers, policymakers, and academics) to participate in the study. While we could 311 
not control which stakeholders would return an expression of interest to participate in the study, 312 
the 24 expressions of interest and the nine participants who completed both rounds of the 313 
survey reflected a range of stakeholder groups and countries and, thus, captured a broad range 314 
of perspectives (see Table 1). The decision of 70% agreement could be a limitation considering 315 
Round 1 was only completed by 16 participants and Round 2 was only completed by nine 316 
participants, as there is some uncertainty as to what constitutes a consensus (27). However, a 317 
recent systematic review (36) noted that few Delphi studies report response rates for all rounds 318 
and stated that the median number of invited participants was only 17 in Delphi studies. 319 
Therefore, we believe that our sample size is sufficient. Additionally, as our sample was chosen 320 
to be purposive, not representative, it can also be concluded that the decrease in participants 321 
from Round 1 to Round 2 is acceptable.  322 
Implications for research 323 
Further research is needed to prioritise the outcomes identified in this study into a core outcome 324 
set to identify the best measures required to evaluate the benefits, challenges and cost-325 
effectiveness of integration of HIV and NCD services in SSA.  326 
Conclusions 327 
This study has identified the key components/outcomes that are most important to a range of 328 
key stakeholders in the field including researchers, policymakers, academics. While our Delphi 329 
panel included experts based outside SSA, we do not see this as being problematic as they were 330 
all experts on integrating diabetes, hypertension and HIV Care in SSA. The findings from this 331 
study will help guide future research when choosing key outcomes/interventions for future 332 
trials in this area and the 22 items prioritised here that met the ≥70% and < 15% criteria will 333 
be useful to improve evidence synthesis in future systematic reviews. The identified key 334 
components are further essential to the generation of a culturally appropriate and transferable 335 
model of integration for potential operationalisation in Africa. 336 
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